Profile
Philippe Pierre Goupit is currently the Chairman at Tollys and also holds a Chairman position at Burgin & Co. He previously worked as a Director at Fovea Pharmaceuticals SA from 2010 to 2013, and as a Director at MedDay Pharmaceuticals SAS from 2014 to 2021.
He also served as an Independent Non-Executive Director at Lysogene SA and as an Independent Director at Inventiva SA from 2015 to 2017.
Prior to that, he worked at Sanofi for 20 years, where he held the position of Vice President-Mergers & Acquisitions.
Goupit obtained his undergraduate degree from Université de Paris 5 René Descartes.
Philippe Pierre Goupit active positions
| Companies | Position | Start |
|---|---|---|
Tollys
Tollys Hospital/Nursing ManagementHealth Services Provides cancer immunotherapy treatment solutions | Chairman | 31/03/2020 |
Burgin & Co. | Chairman | - |
Former positions of Philippe Pierre Goupit
| Companies | Position | End |
|---|---|---|
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Director/Board Member | 31/12/2020 |
| INVENTIVA | Director/Board Member | 29/05/2017 |
| SANOFI | Investor Relations Contact | 30/11/2014 |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Director/Board Member | 31/12/2012 |
| LYSOGENE | Director/Board Member | - |
Training of Philippe Pierre Goupit
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Université de Paris 5 René Descartes
Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Provides cancer immunotherapy treatment solutions | Health Services |
Burgin & Co. |
- Stock Market
- Insiders
- Philippe Pierre Goupit
















